Anna N Chard, Chiedza Machingaidze, Sergio Loayza, Radhika Gharpure, Francisco Nogareda, Rosalba González, Rhina Domínguez, Yeny O Tinoco, Fatimah S Dawood, Joseph Daniel Carreon, Kathryn E Lafond, Jorge Jara, Eduardo Azziz-Baumgartner, Vanessa Cozza, Paula Couto, Melissa A Rolfes, Stefano Tempia
BACKGROUND: Estimating the burden of disease averted by vaccination can assist policymakers to implement, adjust, and communicate the value of vaccination programs. Demonstrating the use of a newly available modeling tool, we estimated the burden of influenza illnesses averted by seasonal influenza vaccination in El Salvador, Panama, and Peru during 2011-2017 among two influenza vaccine target populations: children aged 6-23 months and pregnant women. METHODS: We derived model inputs, including incidence, vaccine coverage, vaccine effectiveness, and multipliers from publicly available country-level influenza surveillance data and cohort studies...
April 6, 2024: Vaccine